NEVIRAPINE ER 400 MG TABLET
For 30 tablets
Pharmacies pay
$47.16 filed
30 × $1.5719 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare
We don’t know yet
No Medicare reference price. Part D: The Part D file flags this drug’s average spending per dosage unit as an outlier, so OpenBill does not use it as a reference price. Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.
The spread
We don’t know yet
There is no Medicare figure to compare with, so there is no spread.
Cost-plus estimate
$59.23 estimated
$47.16 + $7.07 (15%) + $5.00 fee per fill = $59.23
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
NEVIRAPINE ER 400 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as nevirapine.
FDA gives its dosage form as tablet, extended release and its route as oral.
Its labelers, the companies named on the label, are Mylan Pharmaceuticals Inc. and Macleods Pharmaceuticals Limited.
FDA’s Established Pharmacologic Class for it is Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor.
The NADAC file of 2026-10-14 prices it under 2 NDCs (National Drug Codes).
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $47.16 for 30 tablets (30 × $1.5719 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
All 2 NDCs
- 00378-4890-93 · Mylan Pharmaceuticals Inc. · $1.5719 per EA · eff. 2026-09-23 filed
- 33342-0238-07 · Macleods Pharmaceuticals Limited · $1.5719 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
1 other product in the NADAC file shares the FDA nonproprietary name nevirapine with NEVIRAPINE ER 400 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| NEVIRAPINE 200 MG TABLET | $0.14722 per EA filed | $0.53231 per EA filed |
| NEVIRAPINE ER 400 MG TABLET this page | $1.5719 per EA filed | We don’t know yet |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 2 NDCs’ NADAC prices is $1.5719 per EA filed.
Of the 13 other products in FDA’s Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor class priced per EA, 10 have a higher middle NADAC price and 3 a lower one. The one in the middle is EDURANT 25 MG TABLET, at $48.04095 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
We don’t know yet; the card above says why.
Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Related pages
Its pharmacologic class
Related in the same class
- JULUCA 50-25 MG TABLET
- PIFELTRO 100 MG TABLET
- ETRAVIRINE 100 MG TABLET
- EDURANT 25 MG TABLET
- EFAVIRENZ 600 MG TABLET